Business, energy, technology, markets and global industry news from Business News Today

Glucotrack

PharmaDeviceNews Glucotrack
Researchers assess clinical data and overlooked drug-development opportunities as Lōkahi Therapeutics expands its ai² Futures Lab to build a capital-efficient biopharma pipeline. Representative image.
Pharma & Biotech

Glucotrack expands Lōkahi Therapeutics ai² Futures Lab to 12 universities

Lōkahi Therapeutics screened 45-plus drug assets for $33,000. Can its university model turn overlooked programs into pipeline deals?

Read More
Representative image of a clinician reviewing implantable glucose sensor technology and digital blood glucose trends, as Glucotrack seeks FDA approval to begin a U.S. clinical study of its continuous blood glucose monitoring system.
Medical Devices & Diagnostics

Why Glucotrack’s CBGM filing could test the next frontier in diabetes monitoring

Wearable CGMs dominate diabetes care. Glucotrack’s implantable CBGM now faces the harder FDA test: durable blood-based proof.

Read More